Search

Your search keyword '"Costa-Pereira, Christiane"' showing total 17 results
Start Over Author "Costa-Pereira, Christiane"
17 results on '"Costa-Pereira, Christiane"'

1. Rhythmic profile of memory T and B-cells along childhood and adolescence

Author

Brito-de-Sousa, Joaquim Pedro, Lima-Silva, Maria Luiza, Costa-Rocha, Ismael Artur da, Júnior, Luiz Roberto Alves de Oliveira, Campi-Azevedo, Ana Carolina, Peruhype-Magalhães, Vanessa, Quetz, Josiane da Silva, Coelho-dos-Reis, Jordana Grazziela Alves, Costa-Pereira, Christiane, Garcia, Cristiana Couto, Antonelli, Lis Ribeiro do Vale, Fonseca, Cristina Toscano, Lemos, Jandira Aparecida Campos, Mambrini, Juliana Vaz de Melo, Souza-Fagundes, Elaine Maria, Teixeira-Carvalho, Andréa, Faria, Ana Maria de Caetano, Gomes, Angelica Oliveira, Torres, Karen Cecília de Lima, and Martins-Filho, Olindo Assis

Published
2023
Full Text
View/download PDF

2. 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil

Author

Campi-Azevedo, Ana Carolina, Peruhype-Magalhaes, Vanessa, Coelho-dos-Reis, Jordana Grazziela, Antonelli, Lis Ribeiro, Costa-Pereira, Christiane, Speziali, Elaine, Reis, Laise Rodrigues, Lemos, Jandira Aparecida, Ribeiro, Jose Geraldo Leite, Camacho, Luiz Antonio Bastos, de Lourdes de Sousa Maia, Maria, de Lima, Sheila Maria Barbosa, Simoes, Marisol, de Menezes Martins, Reinaldo, Homma, Akira, Malaquias, Luiz Cosme Cota, Tauil, Pedro Luiz, Vasconcelos, Pedro Fernando Costa, Romano, Alessandro Pecego Martins, Domingues, Carla Magda, Teixeira-Carvalho, Andrea, and Martins-Filho, Olindo Assis

Subjects
Vaccines, Biological response modifiers, Yellow fever, B cells, Vaccination, Interferon, Antibodies, T cells, Memory, Immune response, Health, World Health Organization
Abstract

Yellow fever (YF) vaccination is recommended for persons living in YF-endemic areas as the most effective strategy to reduce the risk for infection (1). The 17D and 17DD live attenuated [...]

Published
2019

4. Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus

Author

Reis, Laise Rodrigues, primary, Costa-Rocha, Ismael Artur da, additional, Campi-Azevedo, Ana Carolina, additional, Peruhype-Magalhães, Vanessa, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Costa-Pereira, Christiane, additional, Otta, Dayane Andriotti, additional, Freire, Larissa Chaves, additional, Lima, Sheila Maria Barbosa de, additional, Azevedo, Adriana de Souza, additional, Schwarcz, Waleska Dias, additional, Ano Bom, Ana Paula Dinis, additional, Silva, Andrea Marques Vieira da, additional, Souza, Alessandro Fonseca de, additional, Castro, Thalita da Matta de, additional, Ferroco, Clara Lucy de Vasconcellos, additional, Filippis, Ana Maria Bispo de, additional, Nogueira, Fernanda de Bruycker, additional, Homma, Akira, additional, Domingues, Carla Magda, additional, Sousa, Eduardo Sérgio Soares, additional, Camacho, Luiz Antônio Bastos, additional, Maia, Maria de Lourdes de Souza, additional, Teixeira-Carvalho, Andréa, additional, and Martins-Filho, Olindo Assis, additional

Published
2022
Full Text
View/download PDF

5. Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine

Author

Costa-Rocha, Ismael Artur da, primary, Campi-Azevedo, Ana Carolina, additional, Peruhype-Magalhães, Vanessa, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Fradico, Jordana Rodrigues Barbosa, additional, Souza-Lopes, Thalles, additional, Reis, Laise Rodrigues, additional, Freire, Larissa Chaves, additional, Costa-Pereira, Christiane, additional, Mambrini, Juliana Vaz de Melo, additional, Maia, Maria de Lourdes de Sousa, additional, Lima, Sheila Maria Barbosa de, additional, Noronha, Tatiana Guimarães de, additional, Xavier, Janaina Reis, additional, Camacho, Luiz Antonio Bastos, additional, Albuquerque, Elizabeth Maciel de, additional, Farias, Roberto Henrique Guedes, additional, Castro, Thalita da Matta de, additional, Homma, Akira, additional, Romano, Alessandro Pecego Martins, additional, Domingues, Carla Magda, additional, Martins, Reinaldo de Menezes, additional, Teixeira-Carvalho, Andréa, additional, and Martins-Filho, Olindo Assis, additional

Published
2019
Full Text
View/download PDF

6. Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children

Author

Campi-Azevedo, Ana Carolina, primary, Reis, Laise Rodrigues, additional, Peruhype-Magalhães, Vanessa, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Antonelli, Lis Ribeiro, additional, Fonseca, Cristina Toscano, additional, Costa-Pereira, Christiane, additional, Souza-Fagundes, Elaine Maria, additional, Costa-Rocha, Ismael Artur da, additional, Mambrini, Juliana Vaz de Melo, additional, Lemos, Jandira Aparecida Campos, additional, Ribeiro, José Geraldo Leite, additional, Caldas, Iramaya Rodrigues, additional, Camacho, Luiz Antônio Bastos, additional, Maia, Maria de Lourdes de Sousa, additional, de Noronha, Tatiana Guimarães, additional, de Lima, Sheila Maria Barbosa, additional, Simões, Marisol, additional, Freire, Marcos da Silva, additional, Martins, Reinaldo de Menezes, additional, Homma, Akira, additional, Tauil, Pedro Luiz, additional, Vasconcelos, Pedro Fernando Costa, additional, Romano, Alessandro Pecego Martins, additional, Domingues, Carla Magda, additional, Teixeira-Carvalho, Andréa, additional, and Martins-Filho, Olindo Assis, additional

Published
2019
Full Text
View/download PDF

7. Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine

Author

Costa-Rocha, Ismael Artur da, primary, Campi-Azevedo, Ana Carolina, additional, Peruhype-Magalhães, Vanessa, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Fradico, Jordana Rodrigues Barbosa, additional, Souza-Lopes, Thalles, additional, Reis, Laise Rodrigues, additional, Freire, Larissa Chaves, additional, Costa-Pereira, Christiane, additional, Mambrini, Juliana Vaz de Melo, additional, Maia, Maria de Lourdes de Sousa, additional, Lima, Sheila Maria Barbosa de, additional, Noronha, Tatiana Guimarães de, additional, Xavier, Janaina Reis, additional, Camacho, Luiz Antonio Bastos, additional, Albuquerque, Elizabeth Maciel de, additional, Farias, Roberto Henrique Guedes, additional, Castro, Thalita da Matta de, additional, Homma, Akira, additional, Romano, Alessandro Pecego Martins, additional, Domingues, Carla Magda, additional, Martins, Reinaldo de Menezes, additional, Teixeira-Carvalho, Andréa, additional, and Martins-Filho, Olindo Assis, additional

Published
2019
Full Text
View/download PDF

8. Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination

Author

Costa-Pereira, Christiane, primary, Campi-Azevedo, Ana Carolina, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Peruhype-Magalhães, Vanessa, additional, Araújo, Márcio Sobreira Silva, additional, do Vale Antonelli, Lis Ribeiro, additional, Fonseca, Cristina Toscano, additional, Lemos, Jandira Aparecida, additional, Malaquias, Luiz Cosme Cote, additional, de Souza Gomes, Matheus, additional, Rodrigues Amaral, Laurence, additional, Rios, Maria, additional, Chancey, Caren, additional, Persi, Harold Richard, additional, Pereira, Jorge Marcelo, additional, de Sousa Maia, Maria de Lourdes, additional, Freire, Marcos da Silva, additional, Martins, Reinaldo de Menezes, additional, Homma, Akira, additional, Simões, Marisol, additional, Yamamura, Anna Yoshida, additional, Farias, Roberto Henrique Guedes, additional, Romano, Alessandro Pecego Martins, additional, Domingues, Carla Magda, additional, Tauil, Pedro Luiz, additional, Vasconcelos, Pedro Fernando Costa, additional, Caldas, Iramaya Rodrigues, additional, Camacho, Luiz Antônio, additional, Teixeira-Carvalho, Andrea, additional, and Martins-Filho, Olindo Assis, additional

Published
2018
Full Text
View/download PDF

9. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences

Author

Ferreira, Clarissa de Castro, primary, Campi-Azevedo, Ana Carolina, additional, Peruhype-Magalhāes, Vanessa, additional, Costa-Pereira, Christiane, additional, Albuquerque, Cleandro Pires de, additional, Muniz, Luciana Feitosa, additional, Yokoy de Souza, Talita, additional, Oliveira, Ana Cristina Vanderley, additional, Martins-Filho, Olindo Assis, additional, and da Mota, Licia Maria Henrique, additional

Published
2017
Full Text
View/download PDF

10. Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies

Author

Campi-Azevedo, Ana Carolina, primary, Peruhype-Magalhães, Vanessa, additional, Coelho-dos-Reis, Jordana Grazziela, additional, Costa-Pereira, Christiane, additional, Yamamura, Anna Yoshida, additional, Lima, Sheila Maria Barbosa de, additional, Simões, Marisol, additional, Campos, Fernanda Magalhães Freire, additional, de Castro Zacche Tonini, Aline, additional, Lemos, Elenice Moreira, additional, Brum, Ricardo Cristiano, additional, de Noronha, Tatiana Guimarães, additional, Freire, Marcos Silva, additional, Maia, Maria de Lourdes Sousa, additional, Camacho, Luiz Antônio Bastos, additional, Rios, Maria, additional, Chancey, Caren, additional, Romano, Alessandro, additional, Domingues, Carla Magda, additional, Teixeira-Carvalho, Andréa, additional, and Martins-Filho, Olindo Assis, additional

Published
2017
Full Text
View/download PDF

11. The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.

Author

Ferreira, Clarissa de Castro, Campi-Azevedo, Ana Carolina, Peruhype-Magalhāes, Vanessa, Costa-Pereira, Christiane, Albuquerque, Cleandro Pires de, Muniz, Luciana Feitosa, Yokoy de Souza, Talita, Oliveira, Ana Cristina Vanderley, Martins-Filho, Olindo Assis, and da Mota, Licia Maria Henrique

Abstract

Introduction: The yellow fever vaccine is a live attenuated virus vaccine that is considered one of the most efficient vaccines produced to date. The original 17D strain generated the substrains 17D-204 and 17DD, which are used for the current production of vaccines against yellow fever. The 17D-204 and 17DD substrains present subtle differences in their nucleotide compositions, which can potentially lead to variations in immunogenicity and reactogenicity. We will address the main changes in the immune responses induced by the 17D-204 and 17DD yellow fever vaccines and report similarities and differences between these vaccines in cellular and humoral immunity . This is a relevant issue in view of the re-emergence of yellow fever in Uganda in 2016 and in Brazil in the beginning of 2017. Areas covered: This article will be divided into 8 sections that will analyze the innate immune response, adaptive immune response, humoral response, production of cytokines, immunity in children, immunity in the elderly, gene expression and adverse reactions. Expert commentary: The 17D-204 and 17DD yellow fever vaccines present similar immunogenicity, with strong activation of the cellular and humoral immune responses. Additionally, both vaccines have similar adverse effects, which are mostly mild and thus are considered safe. [ABSTRACT FROM PUBLISHER]

Published
2018
Full Text
View/download PDF

12. Booster dose after 10 years is recommended following 17DD-YF primary vaccination

Author

Campi-Azevedo, Ana Carolina, primary, Costa-Pereira, Christiane, additional, Antonelli, Lis R, additional, Fonseca, Cristina T, additional, Teixeira-Carvalho, Andréa, additional, Villela-Rezende, Gabriela, additional, Santos, Raiany A, additional, Batista, Maurício A, additional, Campos, Fernanda M, additional, Pacheco-Porto, Luiza, additional, Melo Júnior, Otoni A, additional, Hossell, Débora MSH, additional, Coelho-dos-Reis, Jordana G, additional, Peruhype-Magalhães, Vanessa, additional, Costa-Silva, Matheus F, additional, de Oliveira, Jaquelline G, additional, Farias, Roberto H, additional, Noronha, Tatiana G, additional, Lemos, Jandira A, additional, von Doellinger, Vanessa dos R, additional, Simões, Marisol, additional, de Souza, Mirian M, additional, Malaquias, Luiz C, additional, Persi, Harold R, additional, Pereira, Jorge M, additional, Martins, José A, additional, Dornelas-Ribeiro, Marcos, additional, Vinhas, Aline de A, additional, Alves, Tatiane R, additional, Maia, Maria de L, additional, Freire, Marcos da S, additional, Martins, Reinaldo de M, additional, Homma, Akira, additional, Romano, Alessandro PM, additional, Domingues, Carla M, additional, Tauil, Pedro L, additional, Vasconcelos, Pedro F, additional, Rios, Maria, additional, Caldas, Iramaya R, additional, Camacho, Luiz A, additional, and Martins-Filho, Olindo Assis, additional

Published
2015
Full Text
View/download PDF

13. Cross-reactivity of commercially available anti-human monoclonal antibodies with canine cytokines: establishment of a reliable panel to detect the functional profile of peripheral blood lymphocytes by intracytoplasmic staining

Author

Moreira, Marcela L., primary, Dorneles, Elaine M. S., additional, Soares, Rodrigo P., additional, Magalhães, Camila P., additional, Costa-Pereira, Christiane, additional, Lage, Andrey P., additional, Teixeira-Carvalho, Andréa, additional, Martins-Filho, Olindo A., additional, and Araújo, Márcio S. S., additional

Published
2015
Full Text
View/download PDF

14. One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis

Author

Costa-Pereira, Christiane, primary, Moreira, Marcela L, additional, Soares, Rodrigo P, additional, Marteleto, Bruno H, additional, Ribeiro, Vitor M, additional, França-Dias, Michelle H, additional, Cardoso, Ludmila M, additional, Viana, Kelvinson F, additional, Giunchetti, Rodolfo C, additional, Martins-Filho, Olindo A, additional, and Araújo, Márcio S S, additional

Published
2015
Full Text
View/download PDF

15. Booster dose after 10 years is recommended following 17DD-YF primary vaccination.

Author

Campi-Azevedo, Ana Carolina, Costa-Pereira, Christiane, Antonelli, Lis R, Fonseca, Cristina T, Teixeira-Carvalho, Andréa, Villela-Rezende, Gabriela, Santos, Raiany A, Batista, Maurício A, Campos, Fernanda M, Pacheco-Porto, Luiza, Melo Júnior, Otoni A, Hossell, Débora MSH, Coelho-dos-Reis, Jordana G, Peruhype-Magalhães, Vanessa, Costa-Silva, Matheus F, de Oliveira, Jaquelline G, Farias, Roberto H, Noronha, Tatiana G, Lemos, Jandira A, and von Doellinger, Vanessa dos R

Published
2016
Full Text
View/download PDF

16. Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Author

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, and Martins-Filho OA

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01211.]., (Copyright © 2019 Costa-Rocha, Campi-Azevedo, Peruhype-Magalhães, Coelho-dos-Reis, Fradico, Souza-Lopes, Reis, Freire, Costa-Pereira, Mambrini, Maia, Lima, Noronha, Xavier, Camacho, Albuquerque, Farias, Castro, Homma, Romano, Domingues, Martins, Teixeira-Carvalho and Martins-Filho.)

Published
2019
Full Text
View/download PDF

17. Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Author

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, and Martins-Filho OA

Subjects
Adult, Antibodies, Neutralizing blood, Dose-Response Relationship, Drug, Double-Blind Method, Follow-Up Studies, Humans, Male, Yellow Fever prevention & control, Yellow Fever Vaccine immunology, Immunologic Memory immunology, Yellow Fever Vaccine administration & dosage
Abstract

The present study aims to determine whether 17DD-YF-specific humoral and cellular immunological memory is maintained 8-years after primary vaccination with subdoses (10,447IU;3,013IU;587IU;158IU;31IU). For this purpose, this follow-up study was carried out in a subset of volunteers ( n = 98) originally enrolled in the dose-response study in 2009 and 46 non-vaccinated controls. Our results demonstrated that vaccinees, who had seroconverted following primary vaccination and had not been revaccinated, present similar neutralizing antibodies levels and YF-specific cellular memory, particularly CMCD4 and EMCD8 as compared to the reference full dose (27,476IU). Although, PRNT seropositivity rates were similar across subgroups (94, 82, 83, 94, 80, and 91%, correspondingly), only doses above 587IU elicited similar iterative proportion of seropositivity rates, calculated as a progressive decrease on seropositivity rates along time (89, 80, 80, and 91%, respectively) as compared to 158IU and 31IU (68 and 46%, respectively). Noteworthy were the strong positive correlations ("EMCD4,EMCD8" and "TNFCD8,IFNCD8") observed in most subdoses, except for 31IU. Major similarities underscored the preserved antibody titers and the outstanding levels of EMCD8, relevant correlates of protection for YF-specific immunity. These findings provide evidences to support the regular use of dose sparing strategy for YF vaccine in adults.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results